Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-130656
Filing Date
2023-05-01
Accepted
2023-05-01 17:03:06
Documents
17
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d497484d10ka.htm   iXBRL 10-K/A 444238
2 EX-31.3 d497484dex313.htm EX-31.3 3677
3 EX-31.4 d497484dex314.htm EX-31.4 3753
9 GRAPHIC g497484g0427043027505.jpg GRAPHIC 2998
  Complete submission text file 0001193125-23-130656.txt   702169

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tmxd-20221231.xsd EX-101.SCH 4989
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmxd-20221231_cal.xml EX-101.CAL 683
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmxd-20221231_def.xml EX-101.DEF 1688
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmxd-20221231_lab.xml EX-101.LAB 21422
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmxd-20221231_pre.xml EX-101.PRE 17204
11 EXTRACTED XBRL INSTANCE DOCUMENT d497484d10ka_htm.xml XML 7784
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-00100 | Film No.: 23874817
SIC: 2834 Pharmaceutical Preparations